检索

标题
作者
Postoperative stress urinary incontinence in patients after various techniques of laser enucleation for benign prostatic hyperplasia
Dibiraliyev C., Markosyan G., Sukhanov R., Olefir Y., Dymov A., Bezrukov E., Gazimiev M.
Use of a combined form of prostate extract and alpha-adrenoblocker in patients after transurethral resection of the prostate
Pavlov V., Kazikhinurov A., Sabirzyanov S., Kazikhinurov R., Karaguzin R.
The questionnaire of integrated assessment of male sexuality is a tool for analyzing a man's sexual functions throughout his life
Kogan M., Efremov M., Medvedev V., Anosov A., Akhokhov Z., Sinyavskaya T., Khmaruk I.
Laparoscopic retropubic adenomectomy in patients with giant prostate adenoma
Podoynicin A., Mamedov E., Amosov N., Romanov D., Kuznetsova D., Kurkayakov I.
Ejaculatory disorders after surgical treatment of benign prostatic hyperplasia
Rustamov M., Galiullin O., Vinarov A.
COMBINATION THERAPY IN THE MANAGEMENT OF URINARY DISORDERS AFTER TRANSURETHRAL RESECTION OF THE PROSTATE
Ergakov D., Martov A.
Conservative management of benign prostatic hyperplasia: are urologists satisfied?
Govorov A.
Experimental study on the efficiency of rectal suppositories with oxidized dextran in patients with benign prostatic hyperplasia
Novikova E., Troitsky A., Ukah H., Selyatitskaya V.
Efficacy of 5a-reductase inhibitors in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia
Nizov A.
Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts
Sivkov A., Golovanov S., Zhukova L.
Disorders of sexual differentiation in children: a critical look at open questions (part II)
Shiryaev N., Kagantsov I., Sizonov V., Dubrov V.
The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)
Loran O., Seregin A.
AGE-RELATED ANDROGEN DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA: HOW TO IMPROVE THE REHABILITATION OF PATIENTS AFTER TRANSURETHRAL SURGERY?
Martov A., Ergakov D.
SILODOSIN IN THE TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA - RESULTS OF RUSSIAN MULTICENTER OBSERVATIONAL STUDY
Pushkar D., Bernikov A., Sadchenko A.
LONG-TERM OUTCOMES OF THE USE OF A-BLOCKERS TAMSULOSIN IN MEN WITH LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G., Tur E.
THE ROLE OF SYSTEMATIZATION OF POSTOPERATIVE COMPLICATIONS IN ASSESSING THE EFFICIENCY AND SAFETY OF SURGICAL METHODS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Giyasov S., Gafarov R., Shodmonova Z., Mukhtarov S., Akilov F.
Analysis of peri- and postoperative results of laser enucleation of the prostate using various techniques
Dibiraliev C., Abdulaev C., Danilov S., Dymov A., Sukhanov R., Bezrukov E.
CURRENT APPROACHES TO CONSERVATIVE TREATMENT OF MEN WITH CONCOMITANT BENIGN PROSTATIC HYPERPLASIA AND ERECTILE DYSFUNCTION
Kamalov A., Takhirzade A.
Efficiency and safety of silodosin for treatment of lower urinary tract symptoms, associated of benign prostatic hyperplasia
Krivoborodov G., Tur E.
Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice
Kuzmenko A., Gyaurgiev T., Kuzmenko G.
Involvement of p2 receptors in the contractile activity of the bladder in patients with benign prostatic hyperplasia
Ziganshin A., Ivanova D., Zubkov E., Sitdykova M.
VITAPROST FORTE IN THE TREAMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: PATHOGENETIC BASICS AND CLINICAL RESULTS
Kuz’min I.
Treatment of patients with lower urinary tract symptoms in Moscow
Pushkar D., Rasner P., Kotenko D., Gerasimov A., Shabalkin S.
Disorders of sexual differentiation in children: a critical look at open questions (part I)
Shiryaev N., Kagantsov I., Sizonov V., Dubrov V.
The effects of combination therapy with 5a-reductase inhibitor and a-blocker on the prognosis of BPH
Neimark A., Davydov A., Aliev R.
ASSOCIATION OF LOWER URINARY TRACT SYMPTOMS AND TESTOSTERONE DEFICIENCY IN MEN WITH TYPE 2 DIABETES
Kogan M., Belousov I., Ibishev H., Cherniy A., Khripun I., Vorobyev S., Sizaykin D.
Review of clinical studies on combination therapy of 5a-reductase inhibitors and аі-blockers in patients with benign prostatic hyperplasia
Spivak L., Lokshin K., Vinarov A.
TRANSURETHRAL ELECTROENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA
Martov A., Ergakov D., Andronov A., Baykov N.
The use of prostate extract preparations in patients after transurethral resection of prostate for its benign hyperplasia
Pavlov V., Kazikhinurov A., Kazikhinurov R., Sabirzyanov S., Saleeva Y., Kazikhinurova K.
Herpes viruses and human papillomavirus in prostate cancer: first results
Mikhaleva L., Kamalov А., Karpov V., Okhobotov D., Akopyan E., Shakhpazyan N., Shaparov B., Nesterova O., Martirosyan L., Ekhoyan М., Osmanov О.
INTRAVESICAL PROSTATIC PROTRUSION IN DIAGNOSING INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G., Efremov N., Bolotov A.
THE USE OF PROSTADOZ IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND COEXISTENT HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA
Antonov A., Gordeev V., Fedorchuk S., Laptev D.
Therapeutic efficacy and safety of monotherapy Alfuprost® MR 10 mg/day in clinical practice
Novikov A., Shpilenya E.
The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis
Kuzmenko A., Vinnik Y., Kuzmenko V., Gyaurgiev T.
EFFICIENCY OF PHOSPHODIESTERASE-5 INHIBITORS FOR TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND CONCOMITANT ERECTILE DYSFUNCTION
Kamalov A., Nizov A.
The efficacy of fesoterodine in patients after transurethral resection of the prostate
Kuz’menko A., Kuz’menko V., Gyaurgiev T.
Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy
Popov S., Guseinov R., Skryabin O., Orlov I., Martov A.
Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines
Vinarov A., Spivak L., Mironov A.
The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination
Alyaev Y., Pshikhachev A., Perekalina A.
Treatment of erectile dysfunction following transvesical prostatectomy
Motin P., Andrjuhin M., Pulbere S., Alekseev O., Agaev N.
Ejaculatory-protective transurethral resection of the prostate
Martov A., Andronov A., Dutov S., Baykov N.
Evaluation of long-term results of the use of entomological drug in the combination therapy of patients with benign prostatic hyperplasia and chronic prostatitis
Kuzmenko A., Kuzmenko V., Gyaurgiev T., Kuzmenko G.
Evaluation of the effect of Alfuprost® MR on detrusor thickness and bladder mass in patients with detrusor hypertrophy caused by benign prostatic hyperplasia
Kuzmenko A., Kuzmenko V., Gyaurgiev T.
COMBINATION DRUG THERAPY IN PATIENTS WITH BPH
Kuz’menko A., Kuz’menko V., Gyaurgiev T.
TRANSABDOMINAL AND TRANSRECTAL ULTRASOUND ASSESSMENT OF INTRAVESICAL PROSTATIC PROTRUSION
Krivoborodov G., Efremov N., Bolotov A.
Our experience of holmium laser enucleation of the prostate
Kutluev M., Safiullin R.
Multicenter randomized study of bovhyalu-ronidase azoximer (Longidaza®) in men after transuretral resection of the prostate
Kotov S., Bolotov A., Belomyttsev S., Surenkov D., Vorobyova A.
A COMPARATIVE CHARACTERISTICS OF TREATMENT RESULTS OF PATIENS WITH BENIGN PROSTATIC HYPERPLASIA IN COMBINATION WITH HYPOGONADISM
Kamalov A., Vasilevskiy R., Okhobotov D., Neplokhov E.
A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue
Ibishev K., Krainy P., Mitusov V., Sizyakin D., Magomedov G.
Comparative study of extraperitoneoscopic adenomectomy and monopolar transurethral resection in surgical management of benign prostatic hyperplasia with prostate volume of 100-180 cm3
Biktimirov R., Martov A., Biktimirov T., Marapov D., Kaputovskij A.
Efficacy of tamsulosin for treating lower urinary tract symptoms in patients with advanced prostate cancer
Govorov A., Vasilyev A., Pushkar D.
Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia
Glybochko P., Alyaev Y., Pshikhachev A., Sorokin N., Dymov A.
Superselective prostatic artery embolization as a preparatory step before turp in the treatment of benign prostatic hyperplasia in patients with large prostates
Nejmark A., Nejmark B., Tachalov M., Arzamascev D., Torbik D.
MORPHOLOGICAL AND FUNCTIONAL CHANGES OF ORGANS OF FEMALE AND MALE REPRODUCTIVE SYSTEMS AT CHANGE OF SEX
Mikhailichenko V., Fesenko V., Khmelnitskaya N., Ozhiganova I., Novikov A., Korolev V., Vasiliev V.
Efficacy and safety of intermittent catheterization for acute urinary retention: a prospective comparative randomized study
Malkhasyan V., Kotov S., Mamaev I., Belomytcev S., Perov R., Pulbere S., Volnukhin A., Pushkar D.
Efficiency and safety of the drug adenoprosin in patients with prostate diseases. A systematic review and meta-analysis
Morozov А., Timofeeva Е., Suvorov А., Allenov S., Spivak L.
RATIONALE OF PHARMACOTHERAPY DURATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (A CLINICAL-MORPHOLOGICAL STUDY)
Sitdykova M., Tsyplakov D., Sitdykov E., Nurtdinov A.
QUALITY OF LIFE IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS AFTER TURP FOR BENIGN PROSTATIC HYPERPLASIA
Pushkar D., Bernikov A., Khodyreva L., Dudareva A., Al'-Shukri S., Amdii R., Aboyan I., Shiranov K., Medvedev V., Efremov M.
The role of angiotensinconverting enzyme and angiotensin II receptors of the second type in the pathogenesis of proliferative diseases of the prostate
Chibichyan M., Chernogubova E., Avetyan A., Lapteva T., Pavlenko I., Kogan M.
Combination of a1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study
Borisov V.
Super-selective prostatic artery embolization for bph treatment
Karpov V., Kapranov S., Shaparov B., Osmolovskiy B., Kamalov D., Kamalov A.
Factors predicting the development of urinary tract disorders in prostatic hyperplasia in elderly men
Dudarev V., Startsev V.
En bloc holmium laser enucleation of the prostate (HOLEP EN BLOC): our experience
Rapoport L., Sorokin N., Sukhanov R., Dymov A., Enikeev D., Davydov D., Danilov S.
Russian experience with Vitaprost Forte suppositories in patients with lower urinary tract symptoms and benign prostatic hyperplasia: comparative analysis of studies
Korneev I.
Monopolar transurethral enucleation of benign prostatic hyperplasia. Our initial experience
Tsarichenko D., Simberdeev R., Glybochko P., Alyaev Y., Rapoport L., Sukhanov R., Sorokin N., Enikeev D., Davydov D.
UROFOGICAF ASPECTS OF THE FOX - FORDYCE DISEASE
Dutov V., Romanov D.
MODIFIED METHOD OF RETROPUBIC PROSTATECTOMY (RMAPE METHOD)
Veliyev E., Sokolov A., Bogdanov A., Ilyushin L.
The comparative analysis of surgical procedures a in patients with benign prostatic hyperplasia and type 2 diabetes mellitus
Volkov S., Mikheev R., Grigoryan O., Andreeva E.
ANALYSIS OF FACTORS AFFECTING THE COMPLIANCE WITH MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA
Malkhasyan V., Rasner P., Gevorkyan A., Semenyakin I., Tedeev A., Pushkar D.
A case of successful plasma transurethral enucleationof benign prostatic hyperplasia the size of 530 cm3
Sevryukov F., Nakagawa K., Kochkin A., Volodin M., Semenychev D.
Outpatient urodynamic monitoring in patients with BPH: world and russian experience
Shaderkin I., Lebedev G., Shaderkina V., Monakov D., Spivak L., Gadzhieva Z., Gazimiev M.
Lower urinary tract symptoms after transurethral resection of the prostate
Ergakov D., Martov A., Turin D., Andronov A.
The current status of surgical treatment of benign prostatic hyperplasia with volume over 80 сс
Biktimirov R., Martov A., Biktimirov T., Kaputovskij A.
The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia
Zhiborev A., Martov A.
Approaches to medical management of patients with high risk of progressing of benign prostatic hyperplasia depending on concomitant erectile dysfunction
Kamalov A., Takhirzade A.
NEW OPPORTUNITIES TO TREAT COMBINED LUTS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA -PREMISES AND ADVANTAGES
Gadzhieva Z., Kazilov Y.
Holmium laser enucleation of the prostate (HOLEP) for small, large and giant prostatic hyperplasia. Practice guidelines. Experience of more than 450 surgeries
Enikeev D., Glybochko P., Alyaev Y., Rapoport L., Enikeev M., Tsarichenko D., Sorokin N., Sukhanov R., Dimov A., Khamraev O., Davydov D., Taratkin M., Simberdeev R.
TREATMENT OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Kaprin A., Kostin A., Vinogradov I., Magamadov E.
PRIMENENIE PROSTAGUT FORTE U BOL'NYKh ADENOMOY PREDSTATEL'NOY ZhELEZY S SOPUTSTVUYuShchIM KhRONIChESKIM PROSTATITOM
Avdoshin V., Pulbere S.
The results of the multicenter prospective comparative study of Fndrogel in men with endogenous testosterone deficiency and lower urinary tract symptoms, associated with benign prostate hyperplasia («Potok»)
Kogan M., Avadieva N., Gevorkyan L., Loginov Y., Metelkin A., Mitin A., Patrikeev A.
COMPARATIVE ASSESSMENT OF TREATMENTS FOR PROSTATE ADENOMA GREATER THAN 100 CM3
Orlov I., Popov S., Martov A., Gallyamov E., Malevich S., Sushina I., Grin’ E., Sanzharov A., Novikov A., Sergeev V., Kochkin A.
COMPLICATIONS OF THE HOLMIUM LASER ENUCLEATION OF PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA
Davydov D., Tsarichenko D., Bezrukov E., Sukhanov R., Vinarov A., Sorokin N., Enikeev D., Dymov A., Danilov S.
An observational randomized study of the efficacy and safety of the drug Longidase®, vaginal and rectal suppositories 3000 iu in the treatment of patients with symptoms of the lower urinary tract on the background of benign prostatic hyperplasia
Kuzmenko A., Kuzmenko V., Gyaurgiev T., Vinnik Y.
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile 146 dysfunction
Kaputovskij A.
A comparison between enucleation of the prostate using holmium and thulium laser in volume over 80 cc: retrospective clinical study with 12-months follow-up
Popov S., Orlov I., Martov A., Malevich S., Sushina I., Grin E., Obidnyak V., Dovganskiy D., Topuzov T.
Patients with newly diagnosed benign prostatic hyperplasia
Meshkov I., Kulchavenya E., Shevchenko S., Neimark A.
Current concept of diagnosis of benign prostatic hyperplasia
Vinnik Y., Andreichikov A., Klimov N.
X-RAY-GUIDED ENDOVASCULAR SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Neimark A., Tachalov M., Neimark B., Torbik D., Arzamastsev D.
Features of diagnosis and treatment of various disorders of urination by physicians of the Republic of Dagestan and other regions of the North Caucasus and Southern Federal districts
Gadzhieva Z., Kazilov Y., Alyaev Y., Aboyan I.
RISK FACTORS FOR ANTERIOR URETHRAL STRICTURES AFTER TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA
Grechenkov A., Glybochko P., Alyaev Y., Bezrukov E., Vinarov A., Butnaru D., Sukhanov R.
Advanced microwave thermotherapy (PLFT®) as a method of choice in the treatment of complicated, inoperable prostatic adenoma
Pushkar D., Dulkin L., Pletner D., Bormotin A., Lyaginsky A.
A multicenter, randomized, parallel, controlled, prospective, open-label study of the efficiency and safety of bovhyaluronidase azoximer in combination therapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia
Rasner P., Al-Shukri A., Shormanov I., Tazhetdinov O., Maksimova A.
Clinical case: bladder necrosis after prostate embolization in a patient with prostatic hyperplasia
Podoynicin A., Mamedov E., Amosov N., Garmash S., Kuznecova D., Shpot E., Mashin G., Maltsagova P.
THE ROLE OF EXTRAPERITONEOSCOPIC ADENOMECTOMY IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA GREATER THAN 80 CM3
Biktimirov R., Martov A., Biktimirov T., Kaputovskii A.
ULTRASOUND INDICATORS OF THE PROSTATE, URINARY BLADDER AND UROFLOWMETRY PARAMETERS IN THE DIAGNOSIS OF INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G., Efremov N., Bolotov A.
Predictors of bladder neck contracture after transurethral procedure on the prostate
Abbosov S., Sorokin N., Kadrev A., Shomarufov A., Nesterova O., Akilov F., Kamalov A.
Economic aspects of treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
Startsev V., Dudarev V., Sevryukov F., Zabrodina N.
The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-naive patients with benign prostatic hyperplasia
Kupriyanov Y., Rasner P., Rokhlikov I., Akrikidi A., Soloviev V., Markov A., Nozdrin E., Logvinov L., Vasilevskiy R., Skrupskiy K., Pushkar D., Putilovskiy M., Epstein O.
First experience with prostate artery embolization for benign prostatic hyperplasia
Soluyanov M., Shumkov O., Smagin M., Nimaev V.
Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms
Amdii R., Al’-Shukri A.
1 - 100 的 104 信息 1 2 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语